The stem cell program at the US National Institutes of Health is facing an uncertain future, Nature reports. The director of the Center for Regenerative Medicine, Mahendra Rao, left at the end of March and, at the time the Nature piece was written, the center's website had been taken down. The website now says that the center is at a "transition point."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.